Emerging Insights on Adverse Events During ART and Implications for Treatment

Download All
In this comprehensive online program led by expert faculty, review clinical strategies for applying the latest safety and tolerability data when selecting or modifying individualized ART regimens for patients with HIV infection.
Fidelia Bernice, PharmD
Pedro Cahn, MD, PhD
Gregory Huhn, MD, MPHTM
Darcy Wooten, MD

ClinicalThought

Recent data presented at CROI 2021 provide insights on the clinical significance of INSTIs and weight gain. Here are my takeaways regarding cardiovascular and metabolic implications of INSTI-associated weight gain.

Darcy Wooten, MD Released: May 5, 2021

Healthcare professionals need better understanding of the processes involved with weight gain in patients taking antiretroviral therapy. New and upcoming data are providing valuable insights.

Gregory Huhn, MD, MPHTM Released: June 17, 2021

Recent trials of switch strategies involving 2-drug regimens aim to maintain strong virologic suppression while minimizing adverse events and maximizing tolerability. Here’s my take.

Pedro Cahn, MD, PhD Released: September 28, 2021

As our patients with HIV achieve longer life expectancies, the potential for drug–drug interactions increases as non-HIV–associated comorbid conditions arise.

Fidelia Bernice, PharmD Released: January 6, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings